This is a paid press release. Contact the press release distributor directly with any inquiries. Business Wire 4 min read The Fundrise Innovation Fund — ticker symbol VCX — will be one of the first and largest public venture capital funds to list on a major U.S. exchange, with over 100,000 existing investors and...

Tyra Biosciences reported a higher net loss for the fourth quarter and full year 2025, while simultaneously advancing its dabogratinib 3x3 clinical strategy and bolstering its leadership team. This combination of deeper losses and intensified late-stage development around dabogratinib in FGFR3-driven diseases is sharpening investor focus on the company’s precision oncology and rare disease ambitions....